InspireMD (NSPR) Current Leases (2021 - 2022)
InspireMD (NSPR) reported Current Leases of $416000.0 for Q3 2022, down 0.95% quarter-over-quarter from $420000.0 in Q4 2021.
InspireMD (NSPR) Current Leases (2021 - 2022) Analysis & Trends
InspireMD has reported Current Leases for 2 years, with the latest figure at $416000.0 in Q3 2022.
- For the quarter ending Q3 2022, Current Leases changed N/A year-over-year to $416000.0; the trailing twelve-month figure through Sep 2022 stood at $416000.0 (changed N/A YoY), and the FY2021 full-year result was $420000.0, changed N/A from the prior year.
- Current Leases for Q3 2022 stood at $416000.0, down from $420000.0 in the prior quarter.
- The five-year high for Current Leases was $420000.0 in Q4 2021, with the low at $416000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 35.80 Mn |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 416,000.00 |
| Dec 31, 2021 | 420,000.00 |